Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

8W9J

Crystal structure of human CLEC12A ectodomain complexed with 50C1 Fab

Summary for 8W9J
Entry DOI10.2210/pdb8w9j/pdb
DescriptorAnti-human CLEC12A antibody 50C1 light chain, Anti-human CLEC12A antibody 50C1 heavy chain, C-type lectin domain family 12 member A (3 entities in total)
Functional Keywordsc-type lectin receptor, inhibitory antibody, clec12a, immune system
Biological sourceHomo sapiens (human)
More
Total number of polymer chains6
Total formula weight143004.07
Authors
Mori, S.,Nagae, M.,Yamasaki, S. (deposition date: 2023-09-05, release date: 2024-03-06, Last modification date: 2024-11-13)
Primary citationMori, S.,Nagae, M.,Yamasaki, S.
Crystal structure of the complex of CLEC12A and an antibody that interferes with binding of diverse ligands.
Int.Immunol., 36:279-290, 2024
Cited by
PubMed Abstract: C-type lectin receptors (CLRs) are a family of pattern recognition receptors, which detect a broad spectrum of ligands via small carbohydrate-recognition domains (CRDs). CLEC12A is an inhibitory CLR that recognizes crystalline structures such as monosodium urate crystals. CLEC12A also recognizes mycolic acid, a major component of mycobacterial cell walls, and suppresses host immune responses. Although CLEC12A could be a therapeutic target for mycobacterial infection, structural information on CLEC12A was not available. We report here the crystal structures of human CLEC12A (hCLEC12A) in ligand-free form and in complex with 50C1, its inhibitory antibody. 50C1 recognizes human-specific residues on the top face of hCLEC12A CRD. A comprehensive alanine scan demonstrated that the ligand-binding sites of mycolic acid and monosodium urate crystals may overlap with each other, suggesting that CLEC12A utilizes a common interface to recognize different types of ligands. Our results provide atomic insights into the blocking and ligand-recognition mechanisms of CLEC12A and leads to the design of CLR-specific inhibitors.
PubMed: 38386511
DOI: 10.1093/intimm/dxae006
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (3.5 Å)
Structure validation

229183

PDB entries from 2024-12-18

PDB statisticsPDBj update infoContact PDBjnumon